Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 33.98 M27.33 M28.21 M20.79 M26.6 M 102.94 M Research & development 187.58 M184.37 M141.17 M121.94 M103.83 M 551.31 M Operating income -221.56 M-211.7 M-169.38 M-142.73 M-130.43 M -654.25 M Non-Operating Income, Total 493 K13.81 M-3.84 M-2.47 M168 K 7.67 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 493 K13.81 M-3.84 M-10.21 M168 K -70 K Unusual income/expense ———7.74 M— — Pretax income -221.07 M-197.89 M-173.22 M-145.2 M-130.26 M -646.57 M Equity in earnings ————— — Taxes 609 K261 K221 K351 K272 K 1.1 M Non-controlling/minority interest ————— — After tax other income/expense 2.84 M1.4 M1.16 M-5.58 M837 K -2.18 M Net income before discontinued operations -221.68 M-198.15 M-173.44 M-145.56 M-130.53 M -647.68 M Discontinued operations ————— — Net income -221.68 M-198.15 M-173.44 M-145.56 M-130.53 M -647.68 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -221.68 M-198.15 M-173.44 M-145.56 M-130.53 M -647.68 M Basic earnings per share (Basic EPS) -2.17-1.94-1.64-1.11-0.88 -5.57 Diluted earnings per share (Diluted EPS) -2.17-1.94-1.64-1.11-0.88 -5.57 Average basic shares outstanding 101.94 M102.37 M105.82 M107.62 M147.62 M — Diluted shares outstanding 101.94 M102.37 M105.82 M107.62 M147.62 M — EBITDA -219.31 M-209.72 M-166.26 M-140.16 M-128.06 M -644.2 M EBIT -221.56 M-211.7 M-169.38 M-142.73 M-130.43 M -654.25 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2.25 M1.98 M3.13 M2.57 M2.37 M 10.04 M